Skip Internal Navigation
The OPPTB, formerly the Obstetric and Pediatric Pharmacology (OPP) Branch, promotes basic, translational, and clinical research to improve the safety and efficacy of pharmaceuticals and to ensure centralization and coordination of research, clinical trials, and drug development activities for obstetric and pediatric populations.
The Branch is responsible for developing and supporting a comprehensive national effort to increase the knowledge base for understanding how to appropriately treat disease during pregnancy, infancy, childhood, and adolescence using therapeutic approaches including medications that are appropriately tested within their target populations.
Implementation of the Best Pharmaceuticals for Children Act (BPCA) activities at the NICHD is among the major activities for the Branch.
Read more about Branch activities in the OPP Branch Report to the NACHHD Council, 2008 (PDF – 303 KB).
- NEW! Slides from the Pre-Application Webinar for the Obstetric-Fetal Pharmacology Research Centers (OPRC) (PDF - 529 KB)
- Best Pharmaceuticals for Children Act (BPCA)
- Funding Opportunity Announcements:
- Translational Research in Pediatric and Obstetric Pharmacology (R01, R03, R21)
- Biomarkers: Bridging Pediatric and Adult Therapeutics (R01, R03, R21)
- Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R01, R03, R21, R43, R41)
- Developmental Pharmacology and Toxicology: Role of Ontogeny (R01, R03, R21)
- Mechanisms of Adverse Drug Reactions in Children (R01, R03)